About the Authors
- Antonieta Medina Lara
-
Affiliation Health Economics Group, Peninsula College of Medicine and Dentistry, Exeter University, Exeter, United Kingdom
- Jesse Kigozi
-
Affiliation Joint Clinical Research Centre, Kampala, Uganda
- Jovita Amurwon
-
Affiliation Medical Research Council/Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda
- Lazarus Muchabaiwa
-
Affiliation University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe
- Barbara Nyanzi Wakaholi
-
Affiliation Medical Research Council/Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda
- Ruben E. Mujica Mota
-
Affiliation Health Economics Group, Peninsula College of Medicine and Dentistry, Exeter University, Exeter, United Kingdom
- A. Sarah Walker
-
Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom
- Ronnie Kasirye
-
Affiliation Medical Research Council/Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda
- Francis Ssali
-
Affiliation Joint Clinical Research Centre, Kampala, Uganda
- Andrew Reid
-
Affiliation University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe
- Heiner Grosskurth
-
Affiliation Medical Research Council/Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda
- Abdel G. Babiker
-
Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom
- Cissy Kityo
-
Affiliation Joint Clinical Research Centre, Kampala, Uganda
- Elly Katabira
-
Affiliation Infectious Diseases Institute, Kampala, Uganda
- Paula Munderi
-
Affiliation Medical Research Council/Uganda Virus Research Institute Research Unit on AIDS, Entebbe, Uganda
- Peter Mugyenyi
-
Affiliation Joint Clinical Research Centre, Kampala, Uganda
- James Hakim
-
Affiliation University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe
- Janet Darbyshire
-
Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom
- Diana M. Gibb
-
Affiliation Medical Research Council Clinical Trials Unit, London, United Kingdom
- Charles F. Gilks
-
* E-mail: gilksc@unaids.org
Affiliation Faculty of Medicine, Imperial College London, London, United Kingdom
- on behalf of the DART Trial Team
Competing Interests
GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim and Abbott Laboratories donated drugs for DART. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: CFG P. Mugyenyi JH AR JD DMG AGB AML ASW P. Munderi. Performed the experiments: P. Mugyenyi HG EK CK P. Munderi RK FS JH AR DMG CFG AGB ASW AML REMM JK JA LM BNW. Analyzed the data: AML REMM. Wrote the paper: AML CFG ASW DMG JK JA LM REMM BNW RK FS AR HG AGB CK EK P. Munderi P. Mugyenyi JH JD.